| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.0006 | 1 |